XYLONOR GEL tube

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
17-11-2021
공공 평가 보고서 공공 평가 보고서 (PAR)
20-05-2019

유효 성분:

cetrimide, Quantity: 1.5 mg/g; lidocaine, Quantity: 50 mg/g

제공처:

Specialites Septodont Pty Ltd

약제 형태:

Gel

구성:

Excipient Ingredients: Spearmint oil; saccharin; macrogol 300; macrogol 4000; macrogol 1500

관리 경로:

Topical, Buccal

패키지 단위:

15g

수업:

Medicine Registered

처방전 유형:

(S2) Pharmacy Medicine

치료 징후:

Topical anaesthesia and disinfection of the mucosa before;,- injections,- extraction of mobile, deciduous or permanent teeth,- extraction of teeth due to pyorrhoea,- adjusting and fitting of crowns & bridges,- lancing of abscesses,- scaling,Prevention of gagging during impression taking.

제품 요약:

Visual Identification: Clear gel; Container Type: Information not supplied by sponsor; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Registered

승인 날짜:

1991-10-03

제품 특성 요약

                                1
AUSTRALIAN PRODUCT INFORMATION – XYLONOR (LIDOCAINE
(LIGNOCAINE), CETRIMIDE) TOPICAL ANAESTHETIC
1
NAME OF THE MEDICINE
Lidocaine (lignocaine), cetrimide
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
XYLONOR SPRAY
Lidocaine (lignocaine) base
............................................... 15 g
Cetrimide
................................................................................
0.15 g
Excipient q.s. ad.
.................................................................. 100
g
Contains Saccharin and Alcohol (ethanol)
XYLONOR GEL
Lidocaine (lignocaine) base
................................................. 5 g
Cetrimide
................................................................................
0.15 g
Excipient q.s. ad.
................................................................. 100
mL
Contains Saccharin
XYLONOR PELLETS
Lidocaine (lignocaine) base
................................................. 5 g
Cetrimide
................................................................................
0.15 g
Excipient q.s. ad.
................................................................. 100
mL
Contains Saccharin
One impregnated pellet contains approximately 100 mg of the above
solution.
For the full list of excipients, see Section 6.1 List of excipients.
XYLONOR is an association of:
•
a powerful anaesthetic, Lidocaine (lignocaine),
a bactericide, Cetrimide, in a non-irritant, water-soluble excipient.
3
PHARMACEUTICAL FORM
XYLONOR GEL: clear gel
XYLONOR PELLETS: solution; pellet soaked in solution
XYLONOR SPRAY: Spray with clear solution
2
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
XYLONOR GEL
Topical anaesthesia and disinfection of the mucosa before:
-
injections
-
extraction of mobile, deciduous or permanent teeth
-
extraction of teeth due to pyorrhoea
-
adjusting and fitting of crowns & bridges
-
lancing of abscesses
-
scaling
Prevention of gagging during impression taking.
XYLONOR PELLETS
Topical anaesthesia and disinfection of the mucosa before:
-
injections
-
extraction of mobile, deciduou
                                
                                전체 문서 읽기